SHEREE MULLICAN: Open Payments
NPI 1386286912 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 44 payments from 16 companies in 2025. Trend: 2023 $1,007 · 2024 $957 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $105 |
| Lilly USA, LLC | 6 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $94 |
| ABBVIE INC. | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| PFIZER INC. | 2 | $45 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| Boston Scientific Corporation | 2 | $35 |
Products named: Kerendia, CAPLYTA, REXULTI, Ozempic, SHINGRIX, Auvelity, VRAYLAR, Saxenda.
Industry payments across TN — which companies pay providers there.
